Spire Wealth Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $143K | Sell |
|
|||||
|
2025
Q2 | $139K | Sell |
|
|||||
|
2025
Q1 | $140K | Sell |
|
|||||
|
2024
Q4 | $175K | Buy |
|
|||||
|
2024
Q3 | $185K | Sell |
|
|||||
|
2024
Q2 | $233K | Sell |
|
|||||
|
2024
Q1 | $308K | Sell |
|
|||||
|
2023
Q4 | $261K | Buy |
|
|||||
|
2023
Q3 | $239K | Buy |
|
|||||
|
2023
Q2 | $255K | Sell |
|
|||||
|
2023
Q1 | $249K | Sell |
|
|||||
|
2022
Q4 | $362K | Buy |
|
|||||
|
2022
Q3 | $308K | Buy |
|
|||||
|
2022
Q2 | $323K | Sell |
|
|||||
|
2022
Q1 | $1.02M | Sell |
|
|||||
|
2021
Q4 | $23.4M | Buy |
|
|||||
|
2021
Q3 | $25.1M | Sell |
|
|||||
|
2021
Q2 | $22.6M | Sell |
|
|||||
|
2021
Q1 | $17.7M | Buy |
|